Sorry, you need to enable JavaScript to visit this website.

Drug-Drug Interaction Study Assessing the Effect of Carbamazepine on nirmatrelvir (PF-07321332) Boosted With Ritonavir

Drug-Drug Interaction Study Assessing the Effect of Carbamazepine on nirmatrelvir (PF 07321332) Boosted With Ritonavir. A Phase 1, Open-Label, Fixed Sequence, 2-Period Crossover Study to Estimate the Effect of Carbamazepine on the Pharmacokinetics of
PF-07321332 Boosted With Ritonavir in Healthy Participants.

Category & Conditions: Coronavirus Disease (COVID-19)
Medicine: PAXLOVID
ClinicalTrials.gov Identifier (NCT): NCT04962230
Protocol ID: C4671014
PrintDownload
Open Plain Language Summary Result: Click here